USA Financial Formulas’s United Therapeutics UTHR Stock Holding History

USA Financial Formulas’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$235K	Buy	434 +433	+43,300%	+$244K	0.04%	117
2026 Q1	$593	Hold	1	–	–	﹤0.01%	373
2025 Q4	$487	Buy	+1	New	+$466	﹤0.01%	379
2025 Q1	–	Sell	-870	Closed	-$307K	–	369
2024 Q4	$307K	Buy	870 +779	+856%	+$286K	0.05%	127
2024 Q3	$32.6K	Buy	+91	New	+$30.7K	0.01%	229
2023 Q4	–	Sell	-227	Closed	-$51.3K	–	551
2023 Q3	$51.3K	Hold	227	–	–	0.08%	202
2023 Q2	$50.1K	Sell	227 -17	-7%	-$3.77K	0.08%	167
2023 Q1	$54.6K	Buy	+244	New	+$60.2K	0.09%	124
2020 Q3	–	Sell	-4,384	Closed	-$530K	–	364
2020 Q2	$530K	Buy	+4,384	New	+$493K	0.39%	46
2015 Q2	–	Sell	-3,167	Closed	-$546K	–	280
2015 Q1	$546K	Buy	+3,167	New	+$483K	0.18%	92

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

USA Financial Formulas's UTHR Position: Q2 2026 in Review

USA Financial Formulas increased its United Therapeutics (UTHR) stake by 43,300% in Q2 2026, buying an estimated $244K and bringing the position to 434 shares worth $235K. The position accounts for 0.04% of the portfolio, ranked #117.

USA Financial Formulas first reported a position in UTHR in Q1 2015 and has held it in 10 quarters since. The position peaked at $546K in Q1 2015. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

USA Financial Formulas held 434 shares of United Therapeutics worth $235K as of Q2 2026.
USA Financial Formulas bought 433 United Therapeutics shares in Q2 2026, an estimated $244K.
United Therapeutics made up 0.04% of USA Financial Formulas's portfolio in Q2 2026, its #117 holding.
USA Financial Formulas first reported a position in United Therapeutics in Q1 2015 and has held it in 10 quarters since.
USA Financial Formulas's United Therapeutics position peaked at $546K in Q1 2015.
880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.